淋巴向的CUR-NLCs递送增强了口服生物可用性:来自双导管老鼠模型的证据

Haoming Chi1, Xiaorui Zhang1,2, Zhiyuan Chen1

  • 1Fujian Key Laboratory of Traditional Chinese Veterinary Medicine and Animal Health, College of Animal Sciences, Fujian Agriculture and Forestry University, Fuzhou 350002, China.

Pharmaceutics
|November 27, 2025
PubMed
概括

含有黄素的纳米结构脂质载体 (CUR-NLCs) 通过利用肠道淋巴运输显著增强口服吸收. 这种方法提供了一个有前途的策略,用于输送像黄素这样的溶解不良药物.